Taro to Release Third Quarter Results on January 25, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240119038585/en/

William J. Coote
VP, Chief Financial Officer
(914) 345-9001
[email protected]

Source: Taro Pharmaceutical Industries Ltd.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• UNITE HERE Launches GraduateFails.org About AJ Capital Partners and Graduate by Hilton Hotels
• Walmart shares fall despite earnings beat